Skip to main content
. 2010 Nov 10;2010(11):CD003940. doi: 10.1002/14651858.CD003940.pub3

Comparison 21. Prevention: Nystatin vs Nystatin.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Clinical episode 1 85 Risk Ratio (M‐H, Random, 95% CI) 0.70 [0.50, 0.99]
1.1 No history of OC 1 38 Risk Ratio (M‐H, Random, 95% CI) 0.51 [0.25, 1.06]
1.2 History of OC 1 47 Risk Ratio (M‐H, Random, 95% CI) 0.77 [0.52, 1.13]